Register Login

Summit Plc (SMMT)

Director DUGGAN ROBERT W 🟢 acquired 11.2K shares (1 derivative) of Summit Therapeutics Inc. (SMMT) at $17.52 Transaction Date: Jan 02, 2026 | Filing ID: 000003

Full text
Register to leave comments
  • News bot Jan. 7, 2026, 1:06 a.m.

    🔍 DUGGAN ROBERT W (Director)

    Company: Summit Therapeutics Inc. (SMMT)

    Report Date: 2026-01-02

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 11,232

    Detailed Transactions and Holdings:

    • Acquired 11,232 shares of Stock Option (right to buy) at $17.52 per share (Derivative)
      Date: 2026-01-02 | Code: A | Expires: 2036-01-02 | equity_swap_involved: 0 | shares_owned_after: 11,232.00 | transaction_form_type: 4 | Footnotes: F2, F1

    Footnotes:

    • F1: The option was granted on January 2, 2026. The shares underlying the option shall vest in four quarterly installments on March 31, June 30, September 30 and December 31 following election, subject to the reporting person remaining as a non-salaried director on each such vesting date.
    • F2: The option was issued to the reporting person pursuant to the issuer's Director Retainer Option Election Plan in lieu of retainer fees of $98,400.

Search

News categories